HCW Biologics Inc. (HCWB)
2.48
-0.03
(-1.20%)
USD |
NASDAQ |
Sep 09, 11:20
HCW Biologics Total Liabilities (Quarterly) : 19.34M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.34M |
| March 31, 2026 | 21.58M |
| December 31, 2025 | 21.76M |
| September 30, 2025 | 27.55M |
| June 30, 2025 | 28.96M |
| March 31, 2025 | 34.85M |
| December 31, 2024 | 37.01M |
| September 30, 2024 | 36.53M |
| June 30, 2024 | 33.12M |
| March 31, 2024 | 21.69M |
| December 31, 2023 | 15.05M |
| Date | Value |
|---|---|
| September 30, 2023 | 11.75M |
| June 30, 2023 | 10.90M |
| March 31, 2023 | 10.92M |
| December 31, 2022 | 9.381M |
| September 30, 2022 | 8.798M |
| June 30, 2022 | 1.243M |
| March 31, 2022 | 1.557M |
| December 31, 2021 | 2.322M |
| September 30, 2021 | 2.394M |
| June 30, 2021 | 4.169M |
| March 31, 2021 | 1.347M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.77M |
| Shareholders Equity (Quarterly) | 7.428M |
| Debt to Equity Ratio | 0.8834 |
| Current Ratio | 0.0611 |
| Net Debt Paydown Yield | 18.28% |